Biotech · Private company
Livzon Pharmaceutical Group Inc.
Track this companyFree. Adds Livzon Pharmaceutical Group Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- LZM009,recombinant humanized anti-PD-1 monoclonal antibody for injectionPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SQ001 125mL/dayPhase 1 · Solid Tumor Refractory to Standard TherapyClinicalTrials.gov · fetched Nov 12, 2026
- SQ001 250mL/dayPhase 1 · Solid Tumor Refractory to Standard TherapyClinicalTrials.gov · fetched Nov 12, 2026
- SQ001 500mL/dayPhase 1 · Solid Tumor Refractory to Standard TherapyClinicalTrials.gov · fetched Nov 12, 2026
- SQ001 625mL/dayPhase 1 · Solid Tumor Refractory to Standard TherapyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in USPHASE1 · COMPLETED · started Oct 3, 2018ClinicalTrials.gov NCT04026321 · fetched Nov 12, 2026
- LZM009 to Treat Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Aug 21, 2017ClinicalTrials.gov NCT03286296 · fetched Nov 12, 2026